Jiangsu Nhwa Pharmaceutical (002262.SZ): Tetrabromine Hydrochloride Tablets obtained drug registration certificate.
Enhua Pharmaceutical (002262.SZ) announced that the company has recently received approval and issuance of chemical drugs by the National Medical Products Administration.
Jiangsu Nhwa Pharmaceutical (002262.SZ) announced that the company has recently obtained the "Drug Registration Certificate" issued by the National Medical Products Administration for the chemical drug tramadol hydrochloride tablets. Tramadol hydrochloride tablets are used for the treatment of severe acute pain in adult patients requiring opioid analgesics, as well as for the substitute treatment of acute pain that is not adequately relieved.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
